Identification of regulatory regions within the KAI1 promoter: A role for binding of AP1, AP2 and p53

Gene

Volumn 302, Issue 1-2, 2003, Pages 155-164

  Marreiros, Alexandra ^a,b   Czolij, Robert ^c   Yardley, Gina ^a,b   Crossley, Merlin ^c   Jackson, Paul ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bladder cancer; KAI1 gene; Metastasis; Transcription factors

Indexed keywords

CD82 ANTIGEN; DNA; MESSENGER RNA; OLIGONUCLEOTIDE; PROTEIN; PROTEIN AP1; PROTEIN AP2; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DNA BINDING; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; REGULATORY MECHANISM; TRANSCRIPTION INITIATION SITE; WILD TYPE;

EID: 0037413668     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(02)01101-0     Document Type: Article

References (29)

1. Adachi M., Taki T., Ieki Y., Huang C.L., Higashiyama M., Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res. 56:1996;1751-1755.
2. Aryee D.N.T., Ambros I., Ambros P.F., Muehlbacher K., Luegmayr A., Yoshie O., Kovar H. Frequent low level expression in Ewing sarcoma family tumours and widespread absence of metastasis suppressor KAI1/CD82 in neuroblastoma. Ped. Res. 52:2002;279-285.
3. Baek S.H., Ohgi K.A., Rose D.W., Koo E.H., Glass C.K., Rosenfeld M.G. Exchange of N-CoR and Tip60 coactivator complexes links gene expression by NF-κB and β-amyloid protein. Cell. 110:2002;55-67.
4. Brown J.L., Russell P.J., Phillips J., Wotherspoon J., Raghavan D. Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. Br. J. Cancer. 61:1990;369-376.
5. Dong J.T., Lamb P.W., Rinker-Schaeffer C.W., Vukanovic J., Ichikawa T., Isaacs J.T., Barrett J.C. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science. 268:1995;884-886.
6. Dong J.T., Suzuki H., Pin S.S., Bova S., Schalken J., Isaacs W.B., Barrett J.C., Isaacs J.T. Down-regulation of the KAI1 metastasis suppressor gene during progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res. 56:1996;4387-4390.
7. Dong J.T., Isaacs W.B., Barrett J.C., Isaacs J.T. Genomic organisation of the human KAI1 metastasis suppressor gene. Genomics. 41:1997;25-32.
8. Huang C.I., Kohno N., Ogawa E., Adachi A., Yagita M., Sawada S., Takabayashi A., Inufusa H., Yoshie O., Miyake M. Correlation of reduction in MRP/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am. J. Pathol. 153:1998;973-983.
9. Huang S., Jean D., Luca M., Tainsky M.A., Bar-Eli M. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumourigenicity and metastasis. EMBO J. 17:1998;4358-4369.
10. Jackson P., Puisieux A. Is the KAI1 metastasis suppressor gene a cellular target of p53? A review of current evidence. Biochem. Biophys. Res. Commun. 278:2000;499-502.
11. Jackson P., Kingsley E.A., Russell P.J. Inverse correlation between KAI1 mRNA levels and invasive behaviour in bladder cancer cell lines. Cancer Lett. 156:2000;9-17.
12. Jackson P., Millar D., Kingsley E., Yardley G., Ow K., Clark S., Russell P.J. Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines. Cancer Lett. 157:2000;169-176.
13. Jackson P., Grimm M.O., Kingsley E.A., Brosius U., Antalis T., Yardley G., Russell P.J. Relationship between expression of KAI1 metastasis suppressor gene mRNA levels and p53 in bladder and prostate cancer cell lines. Urol. Oncol. 7:2002;99-104.
14. Jean D., Gershenwald J.E., Huang S., Luca M., Hudson M.J., Tainsky M.A., Bar-Eli M. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumour growth and metastasis of human melanoma cells. J. Biol. Chem. 273:1998;16501-16508.
15. Kawana Y., Komiya A., Ueda T., Nihei N., Kuramochi H., Suzuki H., Yatani R., Imai T., Dong J.T., Imai T., Yoshie O., Barrett J.C., Isaacs J.T., Shimazaki J., Ito H., Ichikawa T. Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced prostate cancer. Prostate. 32:1997;205-213.
16. Lu A., Zhang F., Gupta A., Liu J. Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells. J. Biol. Chem. 277:2002;31364-31372.
17. Mashimo T., Watabe M., Hirota S., Hosobe S., Miura K., Tegtmeyer P., Rinker-Schaeffer C.W., Watabe K. The expression of the KAI1 gene, a metastasis suppressor, is directly activated by p53. Proc. Natl. Acad. Sci. USA. 95:1998;11307-11311.
18. Mashimo T., Bandyopadhyay S., Goodarzi G., Watabe S., Pai K., Gross S.C., Watabe K. Activation of the tumour metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-jun genes. Biochem. Biophys. Res. Commun. 274:2000;370-376.
19. McPherson L.A., Loktev A.V., Weigel R.J. Tumor suppressor activity of AP2a mediated through a direct interaction with p53. J. Biol. Chem. 277, 45025-45033.
20. Ow K., Delprado W., Fisher R., Barrett J., Yu Y., Jackson P., Russell P.J. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer. J. Pathol. 191:2000;39-47.
21. Phillips K.K., White A.E., Hicks D.J., Welch D.R., Barrett J.C., Wei L.L., Weissman B.E. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Mol. Carcinogen. 21:1998;111-120.
22. Ruiz M., Troncoso P., Bruns C., Bar-Eli M. Activator protein 2a transcription factor expression is associated with luminol differentiation and is lost in prostate cancer. Clin. Cancer Res. 7:2001;4086-4095.
23. Russell P.J., Jelbart M., Wills E., Singh S., Wass J., Wotherspoon J., Raghavan D. Establishment and characterisation of a new human bladder cancer cell line showing features of squamous and glandular differentiation. Int. J. Cancer. 41:1988;74-82.
24. Russell P.J., Wass J., Lukeis R., Garson O.M., Jelbart M., Wills E., Phillips J., Brown J., Carrington N., Vincent P.C., Ragahavan D. Characterisation of cell lines derived from a multiply aneuploid human bladder transitional cell carcinoma, UCRU-BL-13. Int. J. Cancer. 44:1989;276-285.
25. Shinohara T., Miki T., Nishimura N., Nokihara H., Hamada H., Mukaida N., Sone S. Nuclear factor κB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53. Cancer Res. 61:2001;673-678.
26. Tagawa T., Arihiro K., Takeshima Y., Hiyama E., Yamasaki M., Inai K. Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma. Jpn. J. Cancer Res. 90:1999;970-976.
27. Takaoka A., Hinoda S., Satoh S., Adachi Y., Itoh F., Adachi M., Imai K. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene. 16:1998;1443-1453.
28. Yang J.L., Jackson P., Yu Y., Yoshie O., Ham J.M., Russell P.J., Crowe P.J. Invasion and metastasis correlate with down-regulation of KAI1 expression in human colon cancer cell lines. GI Cancer. 3:2001;313-322.
29. Yardley G., Zauberman A., Oren M., Jackson P. Individual promoter and intron p53-binding motifs from the rat Cyclin G1 promoter region support transcriptional activation by p53, but do not show co-operative activation. FEBS Lett. 430:1998;171-175.